Amgen

Open: 265.0 Close: 263.19 Change: -1.81

How to get information about Amgen Stock without reading the whole internet.

Are looking for the most relevant information about Amgen? Investor spend a lot of time searching for information to make investment decisions in Amgen. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Amgen are: Amgen, employee, Horizon, lay, Therapeutics, acquisition, patient, and the most common words in the summary are: amgen, new, best, open, job, stock, window, . One of the sentences in the summary was: Amgen has been on a cost-cutting spree this year.. Other searches related to this …

Concept Map

Semantic Network

Stock Summary

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's products include Enbrel, Prolia, Xgeva, Otezla, Aranesp, and Repatha..

Today's Summary

Amgen to lay off 350 Horizon employees after closing $27.8 billion deal. Amgen has been on a cost-cutting spree this year.

Today's News

Amgen said Tuesday it will lay off 350 employees of Horizon Therapeutics, many of them based in Deerfield, less than three weeks after it completed its $27.8 billion acquisition of Horizon. The biotech company has about 2,000 employees globally. Amgen announced new Phase 3 CodeBreaK 300 results for its KRASG12C inhibitor combination in patients with metastatic colorectal cancer (mCRC) Amgen to lay off 350 horizon employees after closing $27.8 billion deal - bloomberg. Amgen plans to lay off 350 workers at Horizon Therapeutics, most of whom work in Deerfield, following Amgens acquisition of the drug company less than three weeks ago. Amgen has been on somewhat of a cost-cutting spree this year, cutting 300 jobs in January and 450 in May. Amgen to cut 350 horizon employees after closing purchase. Amgen reached an agreement with the FTC in which Amgen agreed not to use certain anticompetitive tactics, and the deal was allowed to move forward. Amgen announces $2.13 per share dividend for the fourth quarter of 2023. Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. Amgen is an Equal Opportunity Employer. The Amgen Safety Net Foundation does not charge patients a fee for its assistance. Associate Manufacturing (Multiple Positions) Live What you will do Lets do this! Lets change the world! Amgen to Webcast Investor Call at 8:00 a.m. October 31, 2023, before the opening of the U.S. market. Amgen completed its acquisition of Horizon Therapeutics. Amgen announces webcast of 2023 third quarter financial results. Amgen-Horizon Merger Clearance a Setback to FTCs Antitrust Enforcement Plans.

Stock Profile

"Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. It has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and research and development collaboration with Neumora Therapeutics, Inc. and Plexium, Inc. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California."

Keywords

This document will help you to evaluate Amgen without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Amgen are: Amgen, employee, Horizon, lay, Therapeutics, acquisition, patient, and the most common words in the summary are: amgen, new, best, open, job, stock, window, . One of the sentences in the summary was: Amgen has been on a cost-cutting spree this year.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #amgen #new #best #open #job #stock #window.